28
Oct
2025

Genovior Biotech Corporation

Exhibitor at CPHI Frankfurt 2025 stand 3.1M34, Finished Dosage Formulations
About Us

Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production
6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs

Generic/Peptide/Biosimilar projects available for out-licensing<...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • TW
  • 2016
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
View company profile
Contact info
  • 88637580280
  • Website
  • 4F No. 50-8 Keyan RD , Zhunan Township , 35053, Miaoll County , Taiwan, China
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 3.1M34, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Semaglutide (GLP-1 Drug)

    Product Semaglutide (GLP-1 Drug)

    API < USD 500 per gram, COA available Finished product
  • CDMO Services

    Product CDMO Services

    Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

    Our services include:

    1. Process Development
    2. Formulation Development
    3. Analytical Development
    ...
  • CDMO Services - API

    Product CDMO Services - API

    small moleculepeptide
    biologics
  • CDMO Services - FDF drugs

    Product CDMO Services - FDF drugs

    VialsPrefilled Syringe
    Injection Pen 
  • Genovior Products - API

    Product Genovior Products - API

    • Azacitidine (Oncology) • Bortezomib (Oncology) • Fulvestrant (Oncology) • Pemetrexed (Oncology) • Ponatinib (Oncology) • Glucagon (Endocrinology) • Octreotide (Endocrinology) • Teriparatide (Osteoporosis)
  • Genovior Products - FDF Drugs List 1

    Product Genovior Products - FDF Drugs List 1

    Azacitidine inj

    Bortezomib inj

    Docetaxel inj

    Doxorubicin inj

    Epirubicin inj

    Fulvestrant inj

    Gemcitabine inj

    ...
  • Genovior Products - FDF Drugs List 2

    Product Genovior Products - FDF Drugs List 2

    Acyclovir inj

    Colistin inj

    Ganciclovir inj

    Teicoplanin inj

    Vancomycin inj

    Levetiracetam inj

    Valproate inj

    ...
  • Interview by Newsweek, time to talk

    Product Interview by Newsweek, time to talk

    Interviewee：Dr. Steve J.P. Hsu (President of Genovior Biotech)